Update of structural MRI-based methods for the early detection of Alzheimer's disease;Aktuelle entwicklungen der strukturellen MRT zur frühdiagnostik der Alzheimer-demenz

Nervenheilkunde

Volumn 24, Issue 2, 2005, Pages 113-119

  Ewers, M ^a   Teipel, S J ^a   Hampel, Horald ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Alzheimer' disease; Fluid registration; Morphometry

Indexed keywords

ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; NERVE DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; REVIEW;

EID: 17044398980     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1629942     Document Type: Review

References (41)

1. McKhann G et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
2. Zamrini E, De Santi S, Tolar M. Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease. Neurobiol Aging 2004; 25: 685-91.
3. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 1991; 2: 239-59.
4. Wilcock GK, Esiri MM. Plaques, tangles and dementia. A quantitative study. Journal of the Neurological Sciences 1982; 56: 343-56.
5. Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 1995; 16: 271-8, discussion 278-84.
6. Braak H, Braak E. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging 1997; 18 (4 Suppl): S85-8.
7. Zakzanis KK, Graham SJ, Campbell Z. A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile. Neuropsychol Rev 2003; 13: 1-18.
8. Juottonen K et al. Comparative MR Analysis of the Entorhinal Cortex and Hippocampus in Diagnosing Alzheimer Disease. AJNR Am J Neuroradiol 1999; 20: 139-44.
9. Dickerson BC et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiology of Aging 2001; 22: 747-54.
10. Killiany RJ et al. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 2002; 58: 1188-96.
11. Price JL et al. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 2001; 58: 1395-402.
12. Teipel SJ et al. Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration. Neurobiol Aging 2003; 24: 85-94.
13. Teipel SJ et al. Progression of corpus callosum atrophy in Alzheimer disease. Arch Neurol 2002; 59: 243-8.
14. Teipel SJ et al. Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease. Neurology 1998; 51: 1381-5.
15. Hampel H et al. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Arch Neurol 1998; 55: 193-8.
16. Murphy DGM et al. Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: correlations with disease severity. Biological Psychiatry 1993; 34: 612-21.
17. DeCarli C et al. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type. Psychiatry Research 1995; 57: 119-30.
18. Tanna NK et al. Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET Data correction. Radiology 1991; 178: 123-30.
19. Alavi A et al. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J Nucl Med 1993; 34: 1681-7.
20. Pearlson GD et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry 1992; 49: 402-8.
21. Seab JP et al. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magnetic Resonance in Medicine 1988; 8: 200-8.
22. Freeborough PA, Fox NC. Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images. J Comput Assist Tomogr 1998; 22: 838-43.
23. Crum WR, Scahill RI, Fox NC. Automated hippocampal segmentation by regional fluid registration of serial MRI: validation and application in Alzheimer's disease. Neuroimage 2001; 13: 847-55.
24. Grenander U, Miller MI. Computational anatomy: An emerging discipline. Quarterly of Applied Mathematics 1998; 65: 617-94.
25. Csernansky JG et al. Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type. Neurology 2000; 55: 1636-43.
26. Wang L et al. Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging. Neuroimage 2003; 20: 667-82.
27. Haller JW et al. Three-dimensional hippocampal MR morphometry with high-dimensional transformation of a neuroanatomic atlas. Radiology 1997; 202: 504-10.
28. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. NeuroImage 2000; 11: 805-21.
29. Chetelat G, Baron JC. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging. Neuroimage 2003; 18: 525-41.
30. Baron JC et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001; 14: 298-309.
31. Frisoni GB et al. Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J Neurol Neurosurg Psychiatry. 2002; 73: 657-64.
32. Rombouts SA et al. Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett 2000; 285: 231-3.
33. Chetelat G et al. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport 2002; 13: 1939-43.
34. Karas GB et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 2004; 23: 708-16.
35. Teipel SJ et al. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry. Brain 2004; 127: 811-24.
36. Bookstein FL. »Voxel-based morphometry« should not be used with imperfectly registered images. Neuroimage 2001; 14: 1454-62.
37. Christensen GE, Rabbitt RD, Miller MI. Deformable templates using large deformation kinetics. IEEE Trans Med Imaging 1996; 5: 1435-47.
38. Fox NC et al. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. The Lancet 2001; 358: 201-5.
39. Scahill RI et al. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 2002; 99: 4703-7.
40. Thompson PM et al. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex 2001; 11: 1-16.
41. Thompson PM et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 2003; 23: 994-1005.